Cheung, Richard Y <br/><br/>
An overview of Canadian and U.S. approaches to drug regulation and responses to postmarket adverse drug reactions.  [electronic resource] 

 -  Journal of diabetes science and technology  Mar 2013 
 - 313-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1932-2968 
<br/><br/><label>Standard No.: </label>10.1177/193229681300700205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Canada<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug and Narcotic Control--legislation & jurisprudence<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Patient Safety--legislation & jurisprudence<br/>Product Surveillance, Postmarketing--methods<br/>Rosiglitazone<br/>Thiazolidinediones--therapeutic use<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence